scispace - formally typeset
E

Edward Livant

Researcher at University of Pittsburgh

Publications -  12
Citations -  816

Edward Livant is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Dapivirine & Placebo. The author has an hindex of 7, co-authored 11 publications receiving 680 citations.

Papers
More filters
Journal ArticleDOI

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

TL;DR: A monthly vaginal ring containing dapivirine reduced the risk of HIV-1 infection among African women, with increased efficacy in subgroups with evidence of increased adherence.
Journal ArticleDOI

Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 gel (VivaGel) in sexually active young women (MTN-004).

TL;DR: VivaGEL was generally well tolerated and comparable with the VivaGel placebo, although there was a higher incidence of low-grade related genital adverse events compared to the HEC placebo gel.
Journal ArticleDOI

Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): An open-label, extension study

Jared M. Baeten, +760 more
- 01 Feb 2021 - 
TL;DR: In this article, the use of a monthly vaginal ring containing 25 mg dapivirine was well tolerated and reduced HIV-1 incidence in women by approximately 30% compared with placebo.